MHCombiotic

MHCombiotic Inc. is a Canadian biotechnology company and University of Calgary spin-off developing next-generation antimicrobial technologies to address antimicrobial resistance, biofilm-associated infections, and complex wound care challenges.

Our proprietary Combiotic™ platform combines complementary antimicrobial components to achieve broad-spectrum activity, antibiofilm performance, low toxicity, and a reduced risk of resistance development. Our lead commercial platform, ComBatic™, includes Health Canada-approved wound care products in lavage and hydrogel formats. These products are designed to support wound cleansing, microbial and biofilm management, wound-bed preparation, moisture balance, and healing.

Our development strategy is supported by intellectual property protection, clinical and preclinical evidence, ISO 13485 and MDSAP quality systems, Canadian and European manufacturing relationships, and ongoing international commercialization activities.

We are seeking partnerships with pharmaceutical and medical-device companies, wound care distributors, healthcare organizations, contract manufacturers, licensing partners, investors, and research groups. Our priority markets include Europe, North America, Asia, and the Middle East.

We are particularly interested in distribution, co-development, licensing, manufacturing, clinical validation, market-entry, and strategic investment opportunities.